Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis.
Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis.
复制标题
DOI:
10.1097/mpa.0b013e3182152fdf
复制
发表时间:
2011-05
期刊:
影响因子:
2.9
通讯作者:
Sahin-Tóth M
中科院分区:
文献类型:
--
作者:
Joergensen MT;Geisz A;Brusgaard K;Schaffalitzky de Muckadell OB;Hegyi P;Gerdes AM;Sahin-Tóth M
In a hereditary pancreatitis family from Denmark we identified a novel intragenic duplication of 9 nucleotides in exon-2 of the human cationic trypsinogen (PRSS1) gene (c.63_71dup) which at the amino-acid level resulted in the insertion of three amino acids within the activation peptide of cationic trypsinogen (p.K23_I24insIDK). The aim of the present study was to characterize the effect of this unique genetic alteration on the function of human cationic trypsinogen. Wild-type and mutant cationic trypsinogens were produced recombinantly and purified to homogeneity. Trypsinogen activation was followed by enzymatic assays and SDS-PAGE. Trypsinogen secretion was measured from transfected HEK 293T cells. Recombinant cationic trypsinogen carrying the p.K23_I24insIDK mutation exhibited >10-fold increased autoactivation. Activation by human cathepsin B was also accelerated by 10-fold. Secretion of the p.K23_I24insIDK mutant from transfected cells was diminished, consistent with intracellular autoactivation. This is the first report of an intragenic duplication within the PRSS1 gene causing hereditary pancreatitis. The accelerated activation of p.K23_I24insIDK by cathepsin B is a unique biochemical property not found in any other pancreatitis-associated trypsinogen mutant. In contrast, the robust autoactivation of the novel mutant confirms the notion that increased autoactivation is a disease-relevant mechanism in hereditary pancreatitis.